載入...
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia
The majority of patients with acute myeloid leukemia (AML) reach complete remission after high-dose chemotherapy. Still, half of these patients experience a relapse due to presence of minimal residual disease (MRD). Here we discuss the poor prognostic role of class II-associated invariant chain pept...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353169/ https://ncbi.nlm.nih.gov/pubmed/25964856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941737 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|